Quote:
Originally Posted by Ocala Mike
Fate has stepped in with this coronavirus thing, sending all vaccine company stocks higher. NVAX may be in line for some funding to develop a vaccine. Moreover, it should be announcing its results of the nanoflu vaccine trial any day now. RSV is on hold and needs funding for another trial.
th
|
Looks like it's trying to break out off a double bottom. Fox News (Cavuto) gave it good publicity over the weekend, but the nanoflu trial news is the key to whether I get my $ back or not.
